Endothelial progenitor cells in pterygium pathogenesis

Eye

Volumn 21, Issue 9, 2007, Pages 1186-1193

  Lee, J K ^a   Song, Y S ^a   Ha, H S ^a   Park, J H ^a   Kim, M K ^a   Park, A J ^a   Kim, J C ^a  

^a Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; SUBSTANCE P; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; CD34 SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PTERYGIUM; STEM CELL;

EID: 34548540254     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702433     Document Type: Article

References (33)

1. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol 1999; 10: 282-288.
2. Gazzard G, Saw SM, Farook M, Koh D, Widjaja D, Chia SE et al. Pterygium in Indonesia: Prevalence, severity and risk factors. Br J Ophthalmol 2002; 86: 1341-1346.
3. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: The Tanjong Pagar survey. Am J Ophthalmol 2001; 131: 176-183.
4. Kennedy M, Kim KH, Harten B, Brown J, Planck S, Meshul C et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci 1997; 38: 2483-2491.
5. Nick G, Rakesb K, Minas T, Dennis W. UVB-mediated induction of IL-6 and 8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002; 43: 3430-3477.
6. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: Immunohistochemical and ELISA analysis. Graef Arch Clin Exp Ophthalmol 1998; 236: 702-708.
7. Risau W. Differentiation of endothelium. FASEB J 1999; 9: 926-933.
8. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779.
9. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005; 11: 261-262.
10. Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J, Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 2002; 33: 1362-1368.
11. + cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
12. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Cir Res 1999; 85: 221-228.
13. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 1991; 173: 1205-1211.
14. Rameshwar P, Ganea D, Gascon P. In vitro stimulatory effect of substance P on hematopoiesis. Blood 1993; 81: 391-398.
15. Noack F, Sotlar K, Thorns C, Smrcek J, Diedrich K, Feller AC et al. VEGF-, KIT protein- and neutral endopeptidase (NEP/CD10 -positive myofibroblasts - precursors of angiogenesis in chorioangiomas? Placenta 2003; 24: 758-766.
16. Rameshwar P, Zhu G, Donnelly RJ, Qian J, Ge H, Goldstein KR et al. The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: An understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell. J Neuroimmunol 2001; 121: 22-31.
17. Pelletier L, Angonin R, Regnard J, Fellmann D, Charbord P. Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A. Br J Haematol 2002; 119: 1083-1089.
18. Nagano T, Nakamura M, Nakata K, Yamaguchi T, Takase K, Okahara A et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2003; 44: 3810-3815.
19. Murphy CJ, Marfurt CF, McDermott A, Bentley E, Abrams GA, Reid TW et al. Spontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effects of topical substance-P with or without IGF-1. Invest Ophthalmol Vis Sci 2001; 42: 2252-2261.
20. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem 1996; 98: 195-201.
21. Nakagami T, Watanabe I, Murakami A, Okisaka S, Ebihara N. Expression of stem cell factor in pterygium. Jpn J Ophthalmol 2000; 44: 193-197.
22. Song YS, Ryu YH, Choi SR, Kim JC. The involvement of adult stem cells originated from bone marrow in the pathogenesis of pterygia. Yonsei Med J 2005; 46: 687-692.
23. Jones DT, Monroy D, Pflugfelder SC. A novel method of tear collection: comparison of transorb TM polyster rods and glass capillary micropipettes. Invest Ophthalmol Vis Sci 1996; 37: 3935, S851.
24. Chan CM, Chew PW, Alsagoff Z, Wong JS, Tan DT. Vascular patterns in pterygium and conjunctival autografting: A pilot study using indocyanine green anterior segment angiography. Br J Ophthalmol 2001; 85 350-353.
25. Maloof PB, Joshi DD, Qian J, Gascón P, Singh D, Rameshwar P. Induction of preprotachykinin-I and neurokinin-1 by adrenocorticotropin and prolactin: Implication for neuroendocrine-immune-hematopoietic axis. J Neuroimmunol 2001; 112: 188-196.
26. Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 1990; 85: 1468-1476.
27. Seifert P, Sekundo W. Capillaries in the epithelium of pterygium. Br J Ophthalmol 1998; 82: 77-81.
28. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174.
29. Troger J, Neyer S, Heufler C, Huemer H, Schmid E, Griesser U et al. Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina. Invest Ophthalmol Vis Sci 2001; 42: 1045-1050.
30. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125-1135.
31. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-189.
32. Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: Involvement in mobilization of stem/progenitor cells. Blood 2002; 99: 44-51.
33. Hiramoto M, Aizawa S, Iwase O, Nakano M, Toyama K, Hoque M et al. Stimulatory effects of substance P on CD34 positive cell proliferation and differentiation in vitro are mediated by the modulation of stromal cell function. Int J Mol Med 1998; 1: 347-354.